| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 427.68B | 452.46B | 421.85B | 369.10B | 352.06B | 392.87B |
| Gross Profit | 104.84B | 113.36B | 105.41B | 86.19B | 90.12B | 99.42B |
| EBITDA | 32.18B | 33.61B | 32.89B | 14.73B | 18.47B | 21.69B |
| Net Income | 17.88B | 12.48B | 25.65B | -2.80B | 2.07B | -819.00M |
Balance Sheet | ||||||
| Total Assets | 418.90B | 410.96B | 423.40B | 390.43B | 369.17B | 371.55B |
| Cash, Cash Equivalents and Short-Term Investments | 27.12B | 36.87B | 35.04B | 37.75B | 36.69B | 44.84B |
| Total Debt | 110.42B | 103.00B | 118.43B | 128.65B | 100.83B | 94.84B |
| Total Liabilities | 266.03B | 265.22B | 282.08B | 291.14B | 261.53B | 259.94B |
| Stockholders Equity | 152.78B | 145.67B | 141.25B | 99.21B | 107.58B | 111.52B |
Cash Flow | ||||||
| Free Cash Flow | 20.09B | 28.76B | 12.53B | -13.64B | -10.89B | -4.02B |
| Operating Cash Flow | 29.95B | 39.26B | 24.72B | -3.15B | 5.92B | 17.40B |
| Investing Cash Flow | -19.18B | -19.63B | -14.34B | -17.62B | -17.60B | -13.78B |
| Financing Cash Flow | -15.28B | -17.86B | -15.71B | 23.27B | 1.68B | -8.85B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥44.87B | 71.35 | ― | 4.43% | 0.63% | -24.87% | |
71 Outperform | ¥75.79B | 9.50 | 8.37% | 3.06% | 4.82% | 55.73% | |
70 Outperform | ¥44.92B | 14.45 | ― | 2.93% | -0.90% | -13.24% | |
70 Outperform | ¥275.82B | 6.34 | 12.24% | 2.31% | -2.36% | -61.50% | |
68 Neutral | ¥28.46B | 9.33 | 14.95% | 0.77% | 6.43% | 368.06% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
47 Neutral | ¥5.14B | 44.10 | ― | 2.01% | 13.56% | ― |